Imago Biosciences, Inc., A Subsidiary Of Merck & Co., Inc., (rahway, New Jersey Usa)

This study followed patients with blood cancers called myeloproliferative neoplasms who had already been taking the experimental drug bomedemstat in earlier trials. The goal was to check the long-term safety and effectiveness of continuing this daily oral medication. Researchers …